Role of Glucagon-like peptide-1 analogue versus Amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm

Medicine & Life Sciences

• Islet Amyloid Polypeptide 88%
• Glucagon-Like Peptide 1 74%
• Type 1 Diabetes Mellitus 56%
• Exenatide 47%
• Insulin 42%
• pramlintide 36%
• Hyperglycemia 31%
• Glucagon 14%
• Meals 12%
• Artificial Pancreas 10%
• Therapeutics 10%
• Lunch 8%
• Carbohydrates 6%
• Glucose 4%

Chemical Compounds

• Amylin 100%
• Glucagon-Like Peptide 1 99%
• Adjuvant 78%
• Insulin Derivative 64%
• Pramlintide 42%
• Glucagon 18%
• Pump 6%
• Carbohydrate 5%
• Glucose 5%

Engineering & Materials Science

• Insulin 84%
• Peptides 82%
• Medical problems 69%
• Closed loop systems 19%
• Carbohydrates 9%
• Glucose 7%
• Pumps 5%
• Monitoring 3%
• Sensors 3%